Valuation: Bionime Corporation

Market Cap 447.48Cr 14Cr 12Cr 11Cr 10Cr 20Cr 1.33TCr 20Cr 134.4Cr 53Cr 655.07Cr 52Cr 51Cr 2.25TCr P/E 2024
-31x
P/E 2025 -22.2x
Enterprise Value 704.85Cr 22Cr 19Cr 18Cr 16Cr 31Cr 2.09TCr 32Cr 211.7Cr 83Cr 1.03TCr 82Cr 81Cr 3.55TCr EV / Sales 2024
3.48x
EV / Sales 2025 3.58x
Free-Float
53.01%
Yield 2024 *
-
Yield 2025 -
1 day+1.58%
1 week+2.12%
Current month+4.14%
1 month+5.46%
3 months-13.45%
6 months+4.89%
Current year-2.69%
1 week 56.1
Extreme 56.1
58
1 month 53.9
Extreme 53.9
59.3
Current year 49.75
Extreme 49.75
72.9
1 year 49.75
Extreme 49.75
73.9
3 years 43.14
Extreme 43.1415
81.92
5 years 43.14
Extreme 43.1415
88.92
10 years 40
Extreme 40.0048
88.92
Manager TitleAgeSince
Chief Executive Officer - 09/07/2010
Director of Finance/CFO - 06/11/2017
Chief Tech/Sci/R&D Officer - 07/11/2018
Director TitleAgeSince
Chairman - 14/04/2003
Director/Board Member - 17/10/2007
Director/Board Member - 15/05/2007
Change 5-day change 1-year change 3-year change Capi.($)
+1.58%+2.12%-14.86%-17.72% 14Cr
-2.46%-4.72%+218.51%+319.86% 2.12TCr
-2.58%+0.14%-41.49%-24.31% 941.26Cr
-0.33%-3.87%+29.92%+26.65% 687.78Cr
-0.86%+9.54%+233.83%-27.04% 542.48Cr
+3.74%-1.63%-21.04%-28.49% 505.01Cr
-4.92%-7.16%-35.91% - 480.27Cr
-1.04%-1.40%-24.07%-25.45% 417Cr
+0.75%-11.50%+60.48%+68.63% 363.71Cr
+0.62%-0.77%-18.68%-43.44% 259.4Cr
Average -0.55%-0.72%+38.67%+27.63% 633.31Cr
Weighted average by Cap. -1.39%-1.74%+87.02%+110.72%

Financials

2024 2025
Net sales 193.37Cr 6.03Cr 5.27Cr 4.86Cr 4.49Cr 8.52Cr 574.64Cr 8.66Cr 58Cr 23Cr 283.08Cr 23Cr 22Cr 973.18Cr 183.86Cr 5.73Cr 5.01Cr 4.62Cr 4.27Cr 8.1Cr 546.36Cr 8.24Cr 55Cr 22Cr 269.15Cr 22Cr 21Cr 925.29Cr
Net income -13Cr -39.64L -34.67L -31.98L -29.54L -56.04L -38Cr -56.99L -3.82Cr -1.5Cr -19Cr -1.49Cr -1.46Cr -64Cr -18Cr -56.17L -49.13L -45.32L -41.86L -79.42L -54Cr -80.76L -5.41Cr -2.13Cr -26Cr -2.11Cr -2.06Cr -91Cr
Net Debt 278.4Cr 8.67Cr 7.59Cr 7Cr 6.46Cr 12Cr 827.3Cr 12Cr 84Cr 33Cr 407.55Cr 33Cr 32Cr 1.4TCr 257.37Cr 8.02Cr 7.01Cr 6.47Cr 5.98Cr 11Cr 764.8Cr 12Cr 77Cr 30Cr 376.76Cr 30Cr 29Cr 1.3TCr
Logo Bionime Corporation
Bionime Corporation is a Taiwan-based company principally engaged in the manufacture and distribution of blood glucose monitoring products. The Company's main products include blood glucose monitoring devices and blood glucose testing chips. Its products are applied in the testing and monitoring of blood glucose density. The Company distributes its products mainly to overseas markets, including Europe, Asia, the Americas and others.
Employees
-
Date Price Change Volume
09/26/09 NT$57.90 +1.58% 60,354
08/26/08 NT$57.00 +0.18% 58,000
07/26/07 NT$56.90 +0.35% 80,601
06/26/06 NT$56.70 0.00% 79,005
03/26/03 NT$56.70 +0.89% 1,13,159

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4737 Stock